Fundraising FoxNevoa Life Sciences Holdings, Inc.
Gilbert, US · Founded 2017 · Delaware corporation · 1 known investors
Find your way into Nevoa Life Sciences Holdings, Inc.
Sign up to see every warm intro you have to Nevoa Life Sciences Holdings, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nevoa Life Sciences Holdings, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CR
Charles RisleyNamed on SEC filing
RH
Robert HartNamed on SEC filing
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$16.4M disclosed across 4 rounds · 2018–2024
▶$5.9MraisedJan 2025 · 5 investors · OtherRule 506(b)
▶$5.9MraisedJan 2025 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Brad EdwardsDirector
- Tim BaroneDirector
- Mike HudsonDirector
- Lou LaskisDirector
- Sanan AbhayDirector
- Martin McGonagleExecutive Officer, Director
- Joe DamicoDirector
- Ernest CunninghamExecutive Officer
- Dan BueschelDirector
- Offering amount
- $5.9M
- Amount sold
- $5.9M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.2MraisedMar 2022 · 4 investors · OtherRule 506(b)
▶$6.2MraisedMar 2022 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Daniel BueschelDirector
- Timothy BaroneDirector
- Michael HudsonExecutive Officer, Director
- Allen ArroyoExecutive Officer
- Ernest CunninghamExecutive Officer
- Louis LaskisDirector
- Brad EdwardsDirector
- Offering amount
- $12M
- Amount sold
- $6.2M
- Proceeds to insiders
- $200K
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$2.9MraisedNov 2019 · 10 investors · OtherRule 506(b)
▶$2.9MraisedNov 2019 · 10 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- ERNEST CUNNINGHAMExecutive Officer
- ROBERT HARTDirector
- LOUIS LASKISDirector
- JOSEPH DAMICODirector
- MICHAEL HUDSONDirector
- TIMOTHY BARONEDirector
- Amount sold
- $2.9M
- Minimum investment
- $50K
- Placement agents
- CADRE ADVISORS LLC
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.5MraisedNov 2018 · 11 investors · OtherRule 506(b)
▶$1.5MraisedNov 2018 · 11 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Charles RisleyDirector
- Timothy BaroneDirector
- Robert HartDirector
- Michael HudsonDirector
- Louis LaskisDirector
- Ernest CunninghamExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $50K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Nevoa Life Sciences Holdings, Inc.'s investors?
- Nevoa Life Sciences Holdings, Inc.'s investors include Red Cell Incubation.
- How much funding has Nevoa Life Sciences Holdings, Inc. raised?
- Nevoa Life Sciences Holdings, Inc. has disclosed $16.4M raised across 4 rounds.
- Where is Nevoa Life Sciences Holdings, Inc. headquartered?
- Nevoa Life Sciences Holdings, Inc. is headquartered in Gilbert, US.